Onconetix, Inc.
Market Cap
$298.92K
P/E Ratio
—
EPS
$1229.73
Dividend Yield
0.00%
52-Week Range
$0.44 — $14.88
Volume
74.41K
Avg Volume
334.73K
Beta
3.52
P/E (TTM)
—
Forward P/E
—
PEG Ratio
-0.03
P/S (TTM)
0.38
P/B (TTM)
0.03
P/FCF
—
EV/EBITDA
—
EV/Sales
—
ROE (TTM)
-1.90%
ROA (TTM)
-0.56%
ROIC
—
Gross Margin
0.78%
Operating Margin
-7.78%
Net Margin
—
Debt/Equity
0.00
Current Ratio
0.66
EPS Growth (YoY)
—
Revenue Growth (YoY)
—
EPS Growth (3Y)
-33.90%
EPS Growth (5Y)
-20.76%
Sales Growth (3Y)
+14.06%
Sales Growth (5Y)
+8.43%
EPS Est (This Year)
$-4012.00
EPS Est (Next Year)
$-4284.00
Dividend Yield
—
Annual Dividend
—
Payout Ratio
—
Frequency
—
Ex-Dividend Date
—
Cash/Share
$5.57
Institutional %
—
Inst. Net Change
—
Insider Net Shares (90d)
—
Outstanding Shares
570.78K
Float
240.29K
Free Float %
42.10%
Sector
Healthcare
Industry
Biotechnology
Country
US
Exchange
NASDAQ
IPO Date
2022-02-18
Employees
12
CEO
Karina Fedasz
Index Membership
—
Website
https://onconetix.gcs-web.com
Onconetix, Inc. (ONCO) is a healthcare company in the biotechnology industry listed on the NASDAQ. With a market capitalization of $298.92K, ONCO is tracked by stockscreenr alongside 25,000+ other tickers. Use the free stock screener to compare ONCO against other stocks using dozens of fundamental and technical filters.
DRMA
Dermata Therapeutics, Inc.
$1.22
+1.67%
$831.50K
VRAX
Virax Biolabs Group Limited
$0.20
+8.74%
$880.11K
AGMB
AgomAb Therapeutics N.V. American Depositary Shares
$13.71
-4.23%
$342.75K
WINT
Windtree Therapeutics, Inc.
$0.02
+100.00%
$674.18K
ELAB
PMGC Holdings Inc.
$4.44
-8.26%
$78.48K
CMND
Clearmind Medicine Inc.
$0.75
+1.35%
$102.49K
No, Onconetix, Inc. (ONCO) does not currently pay a regular dividend. The company may be reinvesting profits into growth, research, or debt reduction instead of returning cash to shareholders through dividends.
Onconetix, Inc. (ONCO) has a market capitalization of $298,917, classifying it as a micro-cap company. Market cap is calculated by multiplying the current share price by the total number of outstanding shares.